How much drug allergies affect quality of life?

Feridun Gurlek, Eyyup Tasdemir


Background: Drug hypersensitivity reactions are considered public health problems due to associated morbidity and socioeconomic costs. The evaluation of health-related quality of life in patients with drug hypersensitivity is still a widely unconsidered topic. The aim of our study is to reveal the effects of drug allergy on the quality of life of patients who apply to our outpatient clinic with the complaint of drug allergy.

Methods: This study is prospective a questionnaire study under supervision. Patients who applied to the University of Health Sciences, Bursa Postgraduate Research and Training Hospital Department of Allergy outpatient clinic between August 2019 and May 2020 with the complaint of drug allergy filled out the quality of life questionnaire (DrHy-Q), and short questionnaire of psychological well-being index (PGWBIs) under the supervision of a specialist physician before the diagnostic procedures.

Results: The study was conducted with 150 cases and 73.3 % (n=110) of the cases were female and 26.7% (n=40) were male. No significant correlation was found between the demographic characteristics of the patients, the observed symptoms, the culprit drugs, familial and individual comorbid and psychological diseases, and DrHY-Q (p>0.05). DrHY-Q was only affected from the type of allergic reaction. A negative statistically significant weak correlation was also detected between the total DrHY-Q score and the PGWBI total score (r: -0.283; p<0.01).

Conclusions: We found that DrHY-Q is sensitive to reaction type and able to discriminative type 1 and type 2 reactions (p=0.017; p<0.05). We think that more comprehensive studies are needed on this subject.


Drug allergy, Drug hypersensitivity, Quality of life

Full Text:



Johansson S, Bieber T, Dahl R, Friedmann P, Lanier B, Lockey R et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol. 2004;113(5):832-6.

Wolbing F, Fischer J, Koberle M, Kaesler S, Biedermann T. About the role and underlying mechanisms of cofactors in anaphylaxis. Allergy. 2013;68(9):1085-92.

Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71(5):684-700.

Guglielmi L, Guglielmi P, Demoly P. Drug hypersensitivity: epidemiology and risk factors. Curr Pharm Des. 2006;12(26):3309-12.

Romano A, Demoly P. Recent advances in the diagnosis of drug allergy. Curr Opin Allergy Clin Immunol. 2007;7(4):299-303.

Bedolla-Barajas M, Puente-Fernández C, Flores-Merino MV, Morales-Romero J, Domínguez-García MV. Self-report prevalence and associated factors to drug hypersensitivity in Mexican young adults. Asia Pac Allergy. 2017;7(3):156-62.

Bavbek S, Çelik GE, Aydın Ö, Erkekol FÖ, Kurşun N, MunganD, et al. Prevalence of hypersensitivity reactions against drugs among adult population in Turkey: a self-reported survey. J Public Health. 2012;20(6):585-92.

Cornejo-García JA, Jurado-Escobar R, Doña I, Perkins JR, Agúndez JA, García-Martín E, et al. The Genetics of Drug Hypersensitivity Reactions. J Investig Allergol Clin Immunol. 2016;26(4):222-32.

Jurado-Escobar R, Perkins JR, García-Martín E, Isidoro-García M, Doña I, Torres MJ, et al. Update on the Genetic Basis of Drug Hypersensitivity Reactions. J Investig Allergol Clin Immunol. 2017;27(6):336-45.

Baiardini I, Braido F, Brandi S, Canonica GW. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol. 2006;97(4):419-28.

Roberts G, Hurley C, Lack G. Development of a quality-of-life assessment for the allergic child or teenager with multisystem allergic disease. J Allergy Clin Immunol. 2003;111(3):491-7.

Bavbek S, Kepil Ozdemir S, Doganay Erdogan B, Karaboga I, Buyukozturk S, Gelincik A, et al. Turkish version of the Drug Hypersensitivity Quality of Life Questionnaire: assessment of reliability and validity. Qual Life Res. 2016;25(1):101-9.

Ay S, Koldas Doğan S, Evcik D, Gök H, Sonel B, Gökmen D. Reliability and validity of psychological general well-being index in Turkish population. Turk J Physic Medic Rehabilit. 2010;56(4):161-9.

Baiardini I, Braido F, Fassio O, Calia R, Canonica GW, Romano A et al. Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Ann Aller Asthm Immunol. 2011;106(4):330-5.

Gastaminza G, Ruiz-Canela M, Andrés-López B, Barasona Villarejo MJ, Cabañas R, García-Núñez I, et al. Quality of life in patients with allergic reactions to medications: influence of a drug allergy evaluation. J Allergy Clin Immunol Pract. 2019;7(8):2714-21.

Moayeri M, Os-Medendorp HV, Baiardini I, Röckmann H. Assessment of validity and reliability of Drug Hypersensitivity Quality of Life Questionnaire The Dutch experience. Eur Ann Allergy Clin Immunol. 2017;49(3):129-34.